NASDAQ: ADAPAdaptimmune Therapeutics PLC Stock Ownership - Who owns Adaptimmune Therapeutics?
Insider buying vs selling
Have Adaptimmune Therapeutics PLC insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gavin Wood | Chief Financial Officer | 2025-09-02 | 96,000 | $0.01 | $960.00Sell |
| William C. Bertrand Jr. | Chief Operating Officer | 2025-08-28 | 207,000 | $0.01 | $2.07kSell |
| Ali Behbahani | Director | 2025-08-18 | 14,671,794 | $0.01 | $176.06kSell |
| Ali Behbahani | Director | 2025-08-15 | 4,828,206 | $0.01 | $53.11kSell |
| Ecor1 Capital LLC | 10% Owner | 2025-07-30 | 27,433,338 | $0.10 | $2.80MSell |
| Ecor1 Capital LLC | 10% Owner | 2025-07-29 | 2,687,460 | $0.10 | $271.43kSell |
| Ecor1 Capital LLC | 10% Owner | 2025-07-28 | 33,931,740 | $0.11 | $3.83MSell |
| Adrian Rawcliffe | Chief Executive Officer | 2025-01-17 | 30,601 | $0.58 | $17.78kSell |
| Elliot Norry | Chief Medical Officer | 2025-01-17 | 5,584 | $0.58 | $3.24kSell |
| William C. Bertrand Jr. | Chief Operating Officer | 2025-01-17 | 5,584 | $0.58 | $3.24kSell |
ADAP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ADAP insiders and whales buy or sell their stock.
ADAP Shareholders
What type of owners hold Adaptimmune Therapeutics PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Anthony A. Florence Jr. | 10.17% | 161,747,668 | $7.93M | Insider |
| Scott D. Sandell | 10.17% | 161,747,668 | $7.93M | Insider |
| Peter W. Sonsini | 10.17% | 161,747,668 | $7.93M | Insider |
| Forest Baskett | 10.17% | 161,747,668 | $7.93M | Insider |
| David M. Mott | 10.17% | 161,747,668 | $7.93M | Insider |
| Ravi Viswanathan | 9.70% | 154,247,668 | $7.56M | Insider |
| Peter J. Barris | 9.70% | 154,247,668 | $7.56M | Insider |
| Patrick J. Kerins | 8.94% | 142,247,668 | $6.97M | Insider |
| M. James Barrett | 8.94% | 142,247,668 | $6.97M | Insider |
| Ecor1 Capital LLC | 6.31% | 100,371,882 | $4.92M | Insider |
ADAP vs Biotech Stocks
Adaptimmune Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.